Financials
Income statement
| Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
| Total reported revenue | 7.2B | 7.0B | 7.6B | 7.0B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 1.0B | 968M | -313M | 985M |
| Other operating expenses | 120M | -21M | 2.1B | 159M |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 3.8B | 3.8B | 1.6B | 3.5B |
| Tax provision | 1.2B | 1.2B | 121M | 1.1B |
| Net income | 2.6B | 2.6B | 1.5B | 2.4B |
| Basic EPS | 0.1 | 0.1 | 0.1 | — |
| Diluted EPS | 0.1 | 0.1 | 0.1 | — |
| Basic average shares | 17.6B | 17.8B | 17.8B | — |
| Diluted average shares | 17.6B | 17.8B | 17.8B | — |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | — | — | — |
| Minority interests | -8M | -8M | 19M | 0 |
| Preferred stock dividends | — | — | — | — |